Nutex Health报告第二季度业绩

2025-08-21 12:47

Nutex Health press release (NASDAQ:NUTX): Q2 Revenue of $244M (+220.6% Y/Y) beats by $67.53M.
Total visits at the Hospital Division were 45,573 for the three months ended June 30, 2025, as compared to 41,208 for the same period in 2024, an increase of 4,365 or 10.6%.
Visits to mature hospitals increased by 0.6% in the three months ended June 30, 2025, as compared to the same period in 2024.
For the three months ended June 30, 2025, the Company collected $175 million in cash, the highest collection amount for any quarter.
Adjusted EBITDA was $71.6 million for the three months ended June 30, 2025, as compared to $6.8 million for the same period in 2024.
Operating cash flow was $27.1 million for the three months ended June 30, 2025, as compared to $13.3 million for the same period in 2024.

More on Nutex Health